Daewoong Pharmaceutical, 10.0% ↑ on COVID-19 (Camostat) Theme Uptrend

On the 17th, the COVID-19 (Camostat) theme rose by 3.13% compared to the previous day, showing strength, while Daewoong Pharmaceutical, which is attracting attention as a related stock, surged by 10.0% compared to the previous day. Daewoong Pharmaceutical is known as a leading pharmaceutical company manufacturing and selling medicines such as Urusa and Albis.

[Graph] Major stock price changes in the COVID-19 (Camostat) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Daewoong Pharmaceutical ranked 2nd out of 4 stocks in the quant financial ranking by exceeding the theme's average scores in growth, stability, and profitability. This can be interpreted as Daewoong Pharmaceutical having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial scores within the theme

※ The quant financial scores are results analyzed by the Robo Algorithm based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.